Adjuvant Therapy for Rectal Cancer

由 Krishnamurthi, Smitha S., Seo, Yuji, Kinsella, Timothy J.
出版 2007

The Impact of Delayed Chemotherapy on Its Completion and Survival Outcomes in Stage II Colon Cancer Patients

由 Xu, Fang, Rimm, Alfred A., Fu, Pingfu, Krishnamurthi, Smitha S., Cooper, Gregory S.
出版 2014

Pancreatic metastases to the colon: an unusual cause of colonic obstruction

由 Park, Deborah Yae-jung, Krishnamurthi, Smitha, Chahal, Prabhleen, Downs-Kelly, Erinn, Morris-Stiff, Gareth
發表在 BMJ Case Rep (2019)

Understanding Multilevel Factors Related to Urban Community Trust in Healthcare and Research

由 Webb Hooper, Monica, Mitchell, Charlene, Marshall, Vanessa J., Cheatham, Chesley, Austin, Kristina, Sanders, Kimberly, Krishnamurthi, Smitha, Grafton, Lena L.
發表在 Int J Environ Res Public Health (2019)

Videoconference Intervention for Distance Caregivers of Patients With Cancer: A Randomized Controlled Trial

由 Douglas, Sara L., Mazanec, Polly, Lipson, Amy R., Day, Kim, Blackstone, Eric, Bajor, David L., Saltzman, Joel, Krishnamurthi, Smitha
發表在 JCO Oncol Pract (2021)

A pilot study of a low glycemic load diet in patients with stage I-III colorectal cancer

由 Treasure, Michelle, Thomas, Alicia, Ganocy, Stephen, Hong, Augustine, Krishnamurthi, Smitha S., Bajor, David L., Berger, Nathan A., Meropol, Neal J.
發表在 J Gastrointest Oncol (2021)

A multicentre phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma

由 Fountzilas, Christos, Gupta, Medhavi, Lee, Sunyoung, Krishnamurthi, Smitha, Estfan, Bassam, Wang, Katy, Attwood, Kristopher, Wilton, John, Bies, Robert, Bshara, Wiam, Iyer, Renuka
發表在 Br J Cancer (2020)

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors

由 Brell, Joanna M., Krishnamurthi, Smitha S., Rath, Linda, Bokar, Joseph A., Savvides, Panayiotis, Gibbons, Joseph, Cooney, Matthew M., Meropol, Neal J., Ivy, Percy, Dowlati, Afshin
出版 2012

Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles

由 Sanborn, Sharon L., Cooney, Matthew M., Dowlati, Afshin, Brell, Joanna M., Krishnamurthi, Smitha, Gibbons, Joseph, Bokar, Joseph A., Nock, Charles, Ness, Anne, Remick, Scot C.
出版 2008

Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers

由 Dowlati, Afshin, Posey, James, Ramanathan, Ramesh K., Rath, Linda, Fu, Pingfu, Chak, Amitabh, Krishnamurthi, Smitha, Brell, Joanna, Ingalls, Stephen, Hoppel, Charles L., Ivy, Percy, Remick, Scot C.
發表在 Cancer Chemother Pharmacol (2009)

A pilot clinical trial of the cytidine deaminase inhibitor tetrahydrouridine combined with decitabine to target DNMT1 in advanced, chemorefractory pancreatic cancer

由 Sohal, Davendra, Krishnamurthi, Smitha, Tohme, Rita, Gu, Xiaorong, Lindner, Daniel, Landowski, Terry H, Pink, John, Radivoyevitch, Tomas, Fada, Sherry, Lee, Zhenghong, Shepard, Dale, Khorana, Alok, Saunthararajah, Yogen
發表在 Am J Cancer Res (2020)

A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma

由 Brell, Joanna M., Krishnamurthi, Smitha S., Javle, Milind, Saltzman, Joel, Wollner, Ira, Pelley, Robert, Dowlati, Afshin, Kantharaj, Belagodu N., Schluchter, Mark D., Rath, Linda, Ivy, S. Percy, Remick, Scot C.
出版 2008

A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors

由 Nock, Charles J., Brell, Joanna M., Bokar, Joseph A., Cooney, Matthew M., Cooper, Brenda, Gibbons, Joseph, Krishnamurthi, Smitha, Manda, Sudhir, Savvides, Panayiotis, Remick, Scot C., Ivy, Percy, Dowlati, Afshin
出版 2009

A phase I study of MK-5108, an oral aurora A kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tum...

由 Amin, Manik, Minton, Susan E., LoRusso, Patricia M., Krishnamurthi, Smitha S., Pickett, Cheryl A., Lunceford, Jared, Hille, Darcy, Mauro, David, Stein, Mark N., Wang-Gillam, Andrea, Trull, Lauren, Lockhart, A. Craig
發表在 Invest New Drugs (2015)

Phase II Study of Dasatinib (BMS-354825) in Patients With Metastatic Adenocarcinoma of the Pancreas

由 Chee, Cheng Ean, Krishnamurthi, Smitha, Nock, Charles J., Meropol, Neal J., Gibbons, Joseph, Fu, PingFu, Bokar, Joseph, Teston, Lois, O'Brien, Timothy, Gudena, Vinay, Reese, Amy, Bergman, Mark, Saltzman, Joel, Wright, John J., Dowlati, Afshin, Brell, Joanna
出版 2013

Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine

由 Krishnamurthi, Smitha S., Brell, Joanna M., Hoppel, Charles L., Egorin, Merrill J., Weaver, Karen C., Li, Xiaolin, Ingalls, Stephen T., Zuhowski, Eleanor G., Schluchter, Mark D., Dowlati, Afshin, Cooney, Matthew M., Gibbons, Joseph, Overmoyer, Beth A., Ivy, S. Percy, Remick, Scot C.
發表在 Cancer Chemother Pharmacol (2008)

PHASE I CLINICAL TRIAL OF TEMOZOLOMIDE AND METHOXYAMINE (TRC-102), AN INHIBITOR OF BASE EXCISION REPAIR, IN PATIENTS WITH ADVANCED SOLID TUMORS

由 Eads, Jennifer R., Krishnamurthi, Smitha S., Saltzman, Joel, Bokar, Joseph A., Savvides, Panos, Meropol, Neal J., Gibbons, Joseph, Koon, Henry, Sharma, Neelesh, Rogers, Lisa, Pink, John J., Xu, Yan, Beumer, Jan H., Riendeau, John, Fu, Pingfu, Gerson, Stanton L., Dowlati, Afshin
發表在 Invest New Drugs (2020)

Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update

由 Sohal, Davendra P.S., Kennedy, Erin B., Khorana, Alok, Copur, Mehmet S., Crane, Christopher H., Garrido-Laguna, Ignacio, Krishnamurthi, Smitha, Moravek, Cassadie, O’Reilly, Eileen M., Philip, Philip A., Ramanathan, Ramesh K., Ruggiero, Joseph T., Shah, Manish A., Urba, Susan, Uronis, Hope E., Lau, Michelle W., Laheru, Daniel
發表在 J Clin Oncol (2018)

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

由 Dizon, Don S., Krilov, Lada, Cohen, Ezra, Gangadhar, Tara, Ganz, Patricia A., Hensing, Thomas A., Hunger, Stephen, Krishnamurthi, Smitha S., Lassman, Andrew B., Markham, Merry Jennifer, Mayer, Erica, Neuss, Michael, Pal, Sumanta Kumar, Richardson, Lisa C., Schilsky, Richard, Schwartz, Gary K., Spriggs, David R., Villalona-Calero, Miguel Angel, Villani, Gina, Masters, Gregory
發表在 J Clin Oncol (2016)

5-fluorouracil enhances the anti-tumor activity of the glutaminase inhibitor CB-839 against PIK3CA-mutant colorectal cancers

由 Zhao, Yiqing, Feng, Xiujing, Chen, Yicheng, Selfridge, J. Eva, Gorityala, Shashank, Du, Zhanwen, Wang, Janet M., Hao, Yujun, Cioffi, Gino, Conlon, Ronald A., Barnholtz-Sloan, Jill S., Saltzman, Joel, Krishnamurthi, Smitha S., Vinayak, Shaveta, Veigl, Martina, Xu, Yan, Bajor, David L., Markowitz, Sanford D., Meropol, Neal J., Eads, Jennifer R., Wang, Zhenghe
發表在 Cancer Res (2020)